ClinicalTrials.Veeva

Menu

Robotic Brace Incorporating Electromyography (EMG) for Moderate Affected Arm Impairment After Stroke

University of Cincinnati logo

University of Cincinnati

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Stroke

Treatments

Behavioral: Repetitive task specific training (RTP) targeting the affected arm
Device: Myomo e100 Robot and repetitive task specific training
Device: Myomo e100 neurorobotic brace

Study type

Interventional

Funder types

Other

Identifiers

NCT01322997
1R03HD062545-01

Details and patient eligibility

About

Stroke is the leading cause of disability in the United States. One of the reasons that it is so disabling is because of upper extremity hemiparesis (weakness in one arm), which is commonly seen after stroke.

The objective of this research is to see if a robotic system worn on the weakened arm like a brace is more useful in improving the strength and coordination of the affected arm, and those of other stroke survivors, than therapy only. Muscle weakness and lack of coordination after a stroke have great effects on how severely disabled the arm is and on quality of life after a stroke.

In this study, patients may be administered a new robotic brace as part of treatment for their affected arms. If they use this brace, your electromyography (EMG) signals will be used to control the powered arm brace. EMG signals are the small electrical signals that result from the actions of the muscles. The system will "listen" to patients' muscles, using small sensors that sit on top of the skin. The device will give the arm a "power-assist" when patients bend or straighten their elbows. The investigators want to test how easy and effective this system is to use. The investigators hypothesize that people using the robot will be more successful in their rehabilitative efforts - and that their movement will improve more - than people receiving traditional therapy.

Enrollment

30 estimated patients

Sex

All

Ages

35 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Upper extremity Fugl Meyer score >10-< 25
  • presence of volitionally activated EMG signal from the paretic biceps brachii of at least 5 ųV in amplitude
  • stroke experienced > 1 month prior to study enrollment;
  • a score > 24 on the Folstein Mini Mental Status Examination (MMSE)
  • age > 35 < 85
  • have experienced one stroke
  • discharged from all forms of physical rehabilitation
  • Myomo brace fits on affected arm properly and without discomfort (i.e., no red marks or discomfort observed in 10 minutes of use during fitting).

Exclusion criteria

  • < 35 years old
  • excessive pain in the affected hand, arm or shoulder, as measured by a score > 5 on a 10-point visual analog scale
  • excessive spasticity at the affected elbow, as defined as a score of > 4 on the Modified Ashworth Spasticity Scale
  • currently participating in any experimental rehabilitation or drug studies
  • apraxia (< 2.5 on the Alexander scale)
  • severe sensory loss in affected hand (Nottingham sensory scale at least 75% of normal)
  • severe language deficits (score < 2 on NIH Stroke Scale question 9)
  • Stroke that occurred in the brainstem
  • A current medical history of uncontrolled cardiovascular, or pulmonary disease, or other disease that would preclude involvement in a therapeutic treatment
  • History of neurological disorder other than stroke (other neurological disorders may affect the upper extremity motor performance of subjects.)
  • Other significant pain or skin irritation in the upper extremity that would be exacerbated if by the use of the brace
  • Substantial contracture of elbow, defined as > 20 degrees of elbow flexion, as measured at the baseline evaluation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 3 patient groups

Myomo + RTP
Experimental group
Description:
This group will be administered a regimen comprised of repetitive task specific practice (RTP) in conjunction with use of the robotic brace described elsewhere in this record.
Treatment:
Device: Myomo e100 Robot and repetitive task specific training
Myomo
Active Comparator group
Description:
Patients in this group will only be administered the robotic brace described elsewhere in this record.
Treatment:
Device: Myomo e100 neurorobotic brace
RTP only
Active Comparator group
Description:
Patients in this group will be administered repetitive task specific practice (RTP), emphasizing use of their affected arms during performance of valued, functional tasks.
Treatment:
Behavioral: Repetitive task specific training (RTP) targeting the affected arm

Trial contacts and locations

1

Loading...

Central trial contact

Stephen Page, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems